Nyrada Inc Health Care
Biotech Healthcare

$0.028 -0.001 (-3.45%)

High $0.03	Low $0.03	Trades 20	Turnover $17,485	Volume 622,600
30 June 2023 at 4:10pm

Market Cap (2-Oct) $132,444,952 (1,377th)	Close (30-Jun) $0.028 0 (0%)	Volume (30-Jun) 622,600	Shortsold (28-Sep) 16 (0.00%) (682nd)
52w High $1.44	52w Low $0.290	P/E -	EPS -0.03

Short Interest

ASIC data, 28 Sep 2026

% Shorted

0.00%

vs 0.00% prior report

Most Shorted Rank

682nd

of 704 shorted ASX stocks

Peak Short

0.06%

Sep 2026

Days to Cover

0.0

at 50d avg vol

View full short position history →

	Subject
	NYR NYR Ann: Cholesterol-Lowering Program Update
	1 (current) 2 3
	NYR NYR Ann: Brain Injury Program Preclinical Development Update
	NYR NYR Ann: Cholesterol-Lowering Program Preclinical Studies Completed
	NYR NYR Ann: Quarterly Activities Report and Appendix 4C
	NYR NYR Ann: Cholesterol-Lowering Program Preclinical Development Update
	NYR NYR Ann: Nyrada Half Year Results FY2023
	NYR NYR Ann: Appendix 4D and Half Year Report to 31 December 2022
	NYR NYR Ann: Quarterly Activities Report and Appendix 4C
	NYR NYR Ann: Collaboration with Walter Reed and UNSW Extended to 2025
	NYR NYR Ann: Notification of cessation of securities - NYR
	NYR NYR Ann: Brain Injury Program Update
	NYR NYR Ann: Results of Meeting
	NYR NYR Ann: AGM Presentation by James Bonnar CEO
	NYR NYR Ann: Nyrada AGM 2022 Chairmans Address
	NYR NYR Ann: Nyrada Receives A$1.2M R&D Tax Incentive Rebate
	NYR NYR Ann: CEO Remuneration Update
	NYR NYR Ann: Quarterly Activities Report and Appendix 4C
	NYR NYR Ann: 2022 AGM Letter to Shareholders and Proxy
	NYR NYR Ann: 2022 AGM Notice of Meeting and Proxy
	NYR NYR Ann: Efficacy Study Published in Journal of Lipid Research
	NYR NYR Ann: Presentation to ShareCafe Hidden Gems Webinar
	NYR NYR Ann: Presentation to E&P Small Caps Health Care Conference
	NYR NYR Ann: Nyrada Reports Full Year FY2022 Results
	NYR NYR Ann: Annual Report to June 30 2022
	NYR NYR Ann: Preliminary Final Report
	NYR NYR Ann: Appendix 4G and Corporate Governance Statement
	NYR NYR Ann: Nyrada Board Changes
	NYR NYR Ann: Initial Director's Interest Notice - GM
	NYR NYR Ann: Final Director's Interest Notice - PM
	NYR NYR Ann: Quarterly Activities Report and Appendix 4C
	NYR NYR Ann: Nyrada PCSK9 Inhibitor Tested in Model of Atherosclerosis
	NYR NYR Ann: Cholesterol-Lowering Program Update
	NYR NYR Ann: Corporate Presentation
	NYR NYR Ann: Brain Injury Program Target Unveiled and Phase I Update
	NYR NYR Ann: European Patent to be Granted for Cholesterol-Lowering Drug
	NYR NYR Ann: Nyrada Quarterly Activities Report & Appendix 4C
	NYR NYR Ann: Investor Roadshow Presentation
	NYR NYR Ann: New Drug Offers Potential Oral Treatment for Concussion
	NYR NYR Ann: Presentation to Meet the CEO Life Sciences Edition
	NYR NYR Ann: Nyrada Half Year Results FY2022
	NYR NYR Ann: Appendix 4D and Half Year Report to 31 December 2021
	NYR NYR Ann: Nyrada Quarterly Activities Report & Appendix 4C
	NYR NYR Ann: Application for quotation of securities - NYR
	NYR NYR Ann: Change of Director's Interest Notice - ID
	NYR NYR Ann: Change of Director's Interest Notice - MF
	NYR NYR Ann: Change of Director's Interest Notice - RW
	NYR NYR Ann: Change of Director's Interest Notice - JM
	NYR NYR Ann: Change of Director's Interest Notice - CC
	NYR NYR Ann: Change of Director's Interest Notice - PM
	NYR NYR Ann: Nyrada Receives A$1.3M R&D Tax Incentive Rebate

Similar Companies

Cann Group

CAN

Creso Pharma

CPH

Ecofibre

EOF

Incannex Healthcare

IHL

Medical Developments International

MVP

Mayne Pharma Group

MYX

Neuren Pharmaceuticals

NEU

Probiotec

PBP

Recce Pharmaceuticals Ltd

RCE

Starpharma Holdings

SPL

End of Day Prices

Date	Close	Volume	Change
02-Oct	$0.52	176,651	+0.02 (4.00%)
01-Oct	$0.50	283,985	0.00 (0.00%)
30-Sep	$0.50	354,834	+0.04 (7.53%)
29-Sep	$0.47	250,727	-0.02 (3.12%)
28-Sep	$0.48	1,218,244	-0.04 (7.69%)
25-Sep	$0.52	467,595	+0.03 (5.05%)
24-Sep	$0.50	823,091	-0.04 (6.60%)
23-Sep	$0.53	894,252	-0.07 (11.67%)
22-Sep	$0.60	382,078	-0.02 (3.23%)
21-Sep	$0.62	573,000	-0.11 (15.07%)
18-Sep	$0.73	0	0.00 (0.00%)
17-Sep	$0.73	0	0.00 (0.00%)
16-Sep	$0.73	170,749	+0.01 (0.69%)
15-Sep	$0.73	495,759	+0.05 (7.41%)
14-Sep	$0.68	485,836	-0.03 (4.93%)
5 up, 7 down, and 3 flat days

Nyrada Inc Health Care
Biotech Healthcare

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Nyrada Inc Health Care Biotech Healthcare

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Nyrada Inc Health Care
Biotech Healthcare